X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (34) 34
animals (27) 27
viruses (19) 19
vaccines (15) 15
article (14) 14
female (14) 14
mice (14) 14
infection (11) 11
macaca mulatta (11) 11
virology (11) 11
vaccines and antiviral agents (10) 10
immunogenicity (9) 9
multidisciplinary sciences (9) 9
adenoviridae - genetics (8) 8
antibodies, neutralizing - immunology (8) 8
antibodies, viral - immunology (8) 8
genetic vectors (8) 8
humans (8) 8
male (8) 8
mice, inbred c57bl (8) 8
rhesus-monkeys (8) 8
simian immunodeficiency virus - immunology (8) 8
antibodies (7) 7
cd8-positive t-lymphocytes - immunology (7) 7
cell biology (7) 7
human immunodeficiency virus--hiv (7) 7
immunology (7) 7
macaques (7) 7
responses (7) 7
genetic vectors - genetics (6) 6
genetic vectors - immunology (6) 6
health aspects (6) 6
immunization (6) 6
vaccination (6) 6
vaccine (6) 6
biochemistry & molecular biology (5) 5
cd4-positive t-lymphocytes - immunology (5) 5
hiv (5) 5
hiv-1 - immunology (5) 5
infections (5) 5
medical research (5) 5
memory (5) 5
monkeys (5) 5
monkeys & apes (5) 5
prevention (5) 5
simian acquired immunodeficiency syndrome - immunology (5) 5
simian immunodeficiency virus - genetics (5) 5
vectors (5) 5
viral vaccines - immunology (5) 5
virus diseases (5) 5
abridged index medicus (4) 4
adenoviridae (4) 4
adenoviruses (4) 4
adoptive transfer (4) 4
aids vaccines - immunology (4) 4
antiretroviral therapy (4) 4
biochemical phenomena, metabolism, and nutrition (4) 4
cells (4) 4
challenge (4) 4
deoxyribonucleic acid--dna (4) 4
dosage and administration (4) 4
effectiveness (4) 4
efficacy (4) 4
hiv-1 env vaccine (4) 4
hiv-1 vaccine (4) 4
immunity (4) 4
in-vivo (4) 4
infectious diseases (4) 4
ipcavd 001 (4) 4
mice, inbred balb c (4) 4
microbiology (4) 4
rhesus monkey (4) 4
saids vaccines - immunology (4) 4
simian immunodeficiency virus (4) 4
studies (4) 4
t-lymphocytes - immunology (4) 4
vaccines, dna - immunology (4) 4
viral load (4) 4
adenoviridae - immunology (3) 3
adenoviruses, human - genetics (3) 3
antiretroviral drugs (3) 3
binding (3) 3
breadth (3) 3
capsid proteins - genetics (3) 3
capsid proteins - immunology (3) 3
cellular immune-responses (3) 3
challenges (3) 3
chronic viral-infection (3) 3
cross-reactivity (3) 3
disease models, animal (3) 3
dna, viral - analysis (3) 3
dna, viral - blood (3) 3
exhaustion (3) 3
hiv infection (3) 3
immunity, cellular (3) 3
immunologic memory (3) 3
lymphocytes (3) 3
lymphocytic choriomeningitis virus (3) 3
medicine, experimental (3) 3
medicine, research & experimental (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Science, ISSN 0036-8075, 09/2016, Volume 353, Issue 6304, pp. 1129 - 1132
Journal Article
Nature, ISSN 0028-0836, 06/2016, Volume 536, Issue 7617, pp. 474 - 478
Zika virus (ZIKV) is a flavivirus that is responsible for the current epidemic in Brazil and the Americas(1,2). ZIKV has been causally associated with fetal... 
CHALLENGE | HEALTHY-ADULTS | IMMUNOGENICITY | AMERICA | NEUTRALIZING ANTIBODY | SAFETY | MULTIDISCIPLINARY SCIENCES | INFECTION | MICE | MODEL | Antibody Specificity | Immunoglobulin G - isolation & purification | Vaccines, DNA - genetics | Zika Virus - genetics | Vaccines, Subunit - genetics | Humans | Viral Vaccines - genetics | Vaccines, DNA - immunology | Adoptive Transfer | Microcephaly - virology | CD4-Positive T-Lymphocytes - immunology | Zika Virus Infection - virology | Antibodies, Neutralizing - immunology | Immunoglobulin G - immunology | Gene Deletion | Brazil | Zika Virus Infection - complications | Female | Zika Virus Infection - prevention & control | Zika Virus - immunology | Microcephaly - complications | Vaccines, Inactivated - genetics | Viral Envelope Proteins - genetics | Vaccines, Subunit - chemistry | Vaccines, Subunit - immunology | Zika Virus - chemistry | Vaccines, DNA - chemistry | Vaccines, Inactivated - immunology | Animals | Viral Envelope Proteins - chemistry | Viral Vaccines - chemistry | Zika Virus Infection - immunology | Antibodies, Viral - immunology | Viral Envelope Proteins - immunology | Mice | CD8-Positive T-Lymphocytes - immunology | Viral Vaccines - immunology | Vaccines, Inactivated - chemistry | Product development | Viral vaccines | Studies | Epidemics | Encephalitis | Immunization | Fetuses | Zika virus | Vaccines | Microcephaly | Deoxyribonucleic acid--DNA
Journal Article
Nature, ISSN 0028-0836, 2014, Volume 512, Issue 1, pp. 74 - 77
The viral reservoir represents a critical challenge for human immunodeficiency virus type 1 (HIV-1) eradication strategies(1-5). However, it remains unclear... 
LATENT INFECTION | REPLICATION | INITIATION | MULTIDISCIPLINARY SCIENCES | ACTIVE ANTIRETROVIRAL THERAPY | VACCINE | PREVENTION | DYNAMICS | IMMUNODEFICIENCY VIRUS-INFECTION | DEPENDS | HIV-1 INFECTION | DNA, Viral - biosynthesis | Macaca mulatta - immunology | Simian Immunodeficiency Virus - growth & development | DNA, Viral - analysis | Male | RNA, Viral - blood | Rectum - virology | Macaca mulatta - virology | Simian Acquired Immunodeficiency Syndrome - virology | Proviruses - genetics | Time Factors | Treatment Failure | Female | Disease Models, Animal | Simian Immunodeficiency Virus - immunology | Virus Replication - drug effects | Anti-Retroviral Agents - therapeutic use | Anti-Retroviral Agents - pharmacology | Viremia - drug therapy | Simian Immunodeficiency Virus - physiology | DNA, Viral - blood | Carrier State - virology | Animals | Simian Acquired Immunodeficiency Syndrome - drug therapy | Simian Acquired Immunodeficiency Syndrome - immunology | Viremia - virology | Anti-Retroviral Agents - administration & dosage | Carrier State - drug therapy | Kinetics | Viral Load - drug effects | Simian Immunodeficiency Virus - drug effects | Physiological aspects | Simian immunodeficiency virus | Virulence (Microbiology) | Studies | Antiretroviral drugs | Lymphocytes | Human immunodeficiency virus--HIV | Infections | Monkeys & apes | Deoxyribonucleic acid--DNA
Journal Article
Nature, ISSN 0028-0836, 2013, Volume 503, Issue 7475, pp. 224 - 228
Journal Article
Science, ISSN 0036-8075, 07/2015, Volume 349, Issue 6245, pp. 320 - 324
Journal Article
The Lancet, ISSN 0140-6736, 07/2018, Volume 392, Issue 10143, pp. 232 - 243
More than 1·8 million new cases of HIV-1 infection were diagnosed worldwide in 2016. No licensed prophylactic HIV-1 vaccine exists. A major limitation to date... 
MEDICINE, GENERAL & INTERNAL | IPCAVD 001 | IMMUNOGENICITY | SAFETY | EFFICACY TRIAL | CELLULAR IMMUNE-RESPONSES | SIV CHALLENGES | ENV VACCINE | PREVENTION | INFECTION | PROTECTIVE EFFICACY | Back Pain - etiology | Abdominal Pain - etiology | Adenoviridae | Double-Blind Method | Aspartate Aminotransferases - analysis | Humans | Middle Aged | Fatigue - etiology | Macaca mulatta | Healthy Volunteers | AIDS Vaccines - adverse effects | Dose-Response Relationship, Drug | Young Adult | Dizziness - etiology | HIV-1 - immunology | Animals | Immunity, Humoral | Adolescent | Adult | Diarrhea - etiology | AIDS Vaccines - administration & dosage | Genetic Vectors | Immunity, Cellular | Clinical trials | Product development | Vaccines | HIV (Viruses) | Back pain | Pandemics | Laboratories | Aluminum | Viruses | Lymphocytes T | Monkeys | Infections | Dosage | Posture | Proteins | Prevention | Randomization | Pain | Gag protein | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Peripheral blood | Safety | Pharmaceutical industry | Vaccinia | Enzyme-linked immunosorbent assay | Binding | Antigens | Medical research | Phenotypes | Immune response | Effectiveness | Health risks | Diarrhea | Durability | Studies | Immunogenicity | Adenoviruses | Federal agencies | Aspartate aminotransferase | Phagocytosis
Journal Article
Journal Article
Nature, ISSN 0028-0836, 12/2016, Volume 540, Issue 7632, pp. 284 - 287
The development of immunologic interventions that can target the viral reservoir in HIV-1-infected individuals is a major goal of HIV-1 research(1,2). However,... 
INDIVIDUALS | VIREMIA | PERSISTENCE | MULTIDISCIPLINARY SCIENCES | ACTIVE ANTIRETROVIRAL THERAPY | MACAQUES | LATENT RESERVOIR | T-CELLS | CHALLENGES | VIRAL RESERVOIR | HIV-1 REMISSION | AIDS Vaccines - immunology | Simian Immunodeficiency Virus - growth & development | DNA, Viral - analysis | Male | RNA, Viral - blood | Macaca mulatta | Vaccinia virus - genetics | Simian Immunodeficiency Virus - isolation & purification | HIV Infections - immunology | Simian Acquired Immunodeficiency Syndrome - virology | Simian Immunodeficiency Virus - genetics | Time Factors | Toll-Like Receptor 7 - immunology | Adenoviridae - genetics | Female | Simian Acquired Immunodeficiency Syndrome - therapy | Simian Immunodeficiency Virus - immunology | Toll-Like Receptor 7 - genetics | RNA, Viral - analysis | Immunity, Innate | Viral Load - immunology | Genetic Vectors - genetics | DNA, Viral - blood | SAIDS Vaccines - genetics | Animals | SAIDS Vaccines - immunology | Simian Acquired Immunodeficiency Syndrome - immunology | Anti-Retroviral Agents - administration & dosage | HIV Infections - therapy | AIDS Vaccines - genetics | Immunity, Cellular | Prevention | TLR7 | Dosage and administration | Viral vaccines | Health aspects | HIV infection | Immunization | Adenoviruses | Human immunodeficiency virus--HIV | Viruses | Vaccines | Monkeys & apes | Viral infections | Index Medicus
Journal Article
Cell, ISSN 0092-8674, 10/2013, Volume 155, Issue 3, p. 531
The global diversity of HIV-1 represents a critical challenge facing HIV-1 vaccine development. HIV-1 mosaic antigens are bioinformatically optimized... 
Journal Article
Nature, ISSN 0028-0836, 11/2018, Volume 563, Issue 7731, pp. 360 - 364
The latent viral reservoir is the critical barrier for the development of a cure for HIV-1 infection. Previous studies have shown direct antiviral activity of... 
CELLS | VIREMIA | STIMULATION | EFFICACY | MULTIDISCIPLINARY SCIENCES | HUMANS | AIDS | LATENT RESERVOIR | HIV-1 REMISSION | Humans | Macaca mulatta - immunology | DNA, Viral - analysis | Male | Adoptive Transfer | CD8 Antigens - deficiency | Viral Load | Anti-HIV Agents - administration & dosage | Macaca mulatta - virology | Antibodies, Neutralizing - immunology | Simian Immunodeficiency Virus - genetics | Immunity, Cellular - drug effects | HIV Antibodies - immunology | Toll-Like Receptor 7 - immunology | Anti-HIV Agents - therapeutic use | Female | Simian Acquired Immunodeficiency Syndrome - therapy | Simian Immunodeficiency Virus - immunology | Toll-Like Receptor 7 - agonists | Pteridines - pharmacology | Immunity, Innate - drug effects | HIV-1 - drug effects | HIV-1 - genetics | CD8 Antigens - immunology | Immunity, Cellular - immunology | Immunity, Innate - immunology | HIV-1 - immunology | Animals | Simian Acquired Immunodeficiency Syndrome - drug therapy | Simian Acquired Immunodeficiency Syndrome - immunology | Antibodies, Viral - immunology | Simian Immunodeficiency Virus - drug effects | Viral antibodies | Antiviral agents | Antibodies | Toll-like receptors | Dosage and administration | Drug therapy | Health aspects | HIV infection | Antiretroviral drugs | Lymphatic system | Immunoglobulins | TLR7 protein | CD8 antigen | Viruses | Infections | Monkeys | Adoptive transfer | Antiretroviral therapy | Glycan | Proteins | Depletion | Antiretroviral agents | Human immunodeficiency virus--HIV | Antiviral activity | Reservoirs | Binding sites | Deoxyribonucleic acid--DNA | Immune system
Journal Article